The role of academic pharmacy in tobacco cessation and control.

Sarah E McBane, Robin L Corelli, Christian B Albano, John M Conry, Mark A Della Paolera, Amy K Kennedy, Antoine T Jenkins, Karen Suchanek Hudmon
Author Information
  1. Sarah E McBane: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California - San Diego, La Jolla, California, USA.

Abstract

Despite decades of public health initiatives, tobacco use remains the leading known preventable cause of death in the United States. Clinicians have a proven, positive effect on patients' ability to quit, and pharmacists are strategically positioned to assist patients with quitting. The American Association of Colleges of Pharmacy recognizes health promotion and disease prevention as a key educational outcome; as such, tobacco cessation education should be a required component of pharmacy curricula to ensure that all pharmacy graduates possess the requisite evidence-based knowledge and skills to intervene with patients who use tobacco. Faculty members teaching tobacco cessation-related content must be knowledgeable and proficient in providing comprehensive cessation counseling, and all preceptors and practicing pharmacists providing direct patient care should screen for tobacco use and provide at least minimal counseling as a routine component of care. Pharmacy organizations should establish policies and resolutions addressing the profession's role in tobacco cessation and control, and the profession should work together to eliminate tobacco sales in all practice settings where pharmacy services are rendered.

Keywords

References

  1. J Contin Educ Health Prof. 2012 Summer;32(3):187-95 [PMID: 23008081]
  2. Nicotine Tob Res. 2005 Apr;7(2):225-32 [PMID: 16036279]
  3. J Am Coll Nutr. 2012 Jun;31(3):145-8 [PMID: 23204149]
  4. Nicotine Tob Res. 2010 Jul;12(7):724-33 [PMID: 20507899]
  5. J Am Pharm Assoc (2003). 2006 Sep-Oct;46(5):616-8 [PMID: 17036649]
  6. J Community Health. 2002 Oct;27(5):321-33 [PMID: 12238731]
  7. J Contin Educ Health Prof. 2011 Fall;31 Suppl 1:S60-6 [PMID: 22190102]
  8. Nicotine Tob Res. 2010 Nov;12(11):1167-71 [PMID: 20937670]
  9. Am J Public Health. 2005 Jun;95(6):950-5 [PMID: 15914815]
  10. JAMA. 2008 Sep 24;300(12):1451-3 [PMID: 18812536]
  11. Am J Pharm Educ. 2006 Aug 15;70(4):75 [PMID: 17136194]
  12. Cochrane Database Syst Rev. 2012 May 16;(5):CD000214 [PMID: 22592671]
  13. Am Pharm. 1986 Jul;NS26(7):25-33 [PMID: 3751881]
  14. Ann Pharmacother. 2010 Sep;44(9):1395-402 [PMID: 20628045]
  15. J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):9-16 [PMID: 20097634]
  16. MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8 [PMID: 19008791]
  17. J Community Health. 2012 Feb;37(1):113-8 [PMID: 21644021]
  18. MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1513-9 [PMID: 22071589]
  19. Arch Intern Med. 2010 Oct 11;170(18):1640-6 [PMID: 20937922]
  20. JAMA. 2005 Jul 27;294(4):482-7 [PMID: 16046655]
  21. Adv Health Sci Educ Theory Pract. 2012 Aug;17(3):305-10 [PMID: 22696095]
  22. Am J Pharm Educ. 2011 Dec 15;75(10):S7 [PMID: 22345754]
  23. Am J Prev Med. 2010 Mar;38(3 Suppl):S393-6 [PMID: 20176313]
  24. BMJ. 2004 Jun 26;328(7455):1519 [PMID: 15213107]
  25. Tob Control. 2012 Sep;21(5):509-10 [PMID: 21953133]
  26. Am J Health Syst Pharm. 2004 Jan 1;61(1):101-2 [PMID: 14725127]
  27. MMWR Morb Mortal Wkly Rep. 2012 Nov 9;61(44):889-94 [PMID: 23134971]
  28. Am J Health Syst Pharm. 2007 Sep 15;64(18):1917-21 [PMID: 17823102]
  29. Am J Health Syst Pharm. 1996 Jan 1;53(1):45-52 [PMID: 8719289]
  30. Am J Public Health. 2009 Sep;99(9):1699-704 [PMID: 19638596]
  31. MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):842-4 [PMID: 12966360]
  32. Pharmacotherapy. 2002 Dec;22(12):1623-31 [PMID: 12495172]
  33. Tob Control. 2004 Dec;13(4):429-32 [PMID: 15564630]
  34. Pharmacotherapy. 2007 Jul;27(7):1040-51 [PMID: 17594210]
  35. Am J Pharm Educ. 2007 Dec 15;71(6):109 [PMID: 19503693]
  36. Cochrane Database Syst Rev. 2004;(1):CD003698 [PMID: 14974031]
  37. J Community Health. 2012 Aug;37(4):848-54 [PMID: 22143162]
  38. Tob Control. 2013 Nov;22(6):369-71 [PMID: 23172399]
  39. Am J Pharm Educ. 2010 Mar 10;74(2):36 [PMID: 20414451]
  40. Patient Educ Couns. 2006 Apr;61(1):152-60 [PMID: 16533683]
  41. Prev Med. 2005 Jun;40(6):888-95 [PMID: 15850892]
  42. Med Princ Pract. 2011;20(3):237-43 [PMID: 21454993]
  43. BMC Public Health. 2011 Nov 08;11:848 [PMID: 22067084]
  44. BMC Res Notes. 2012 Aug 06;5:413 [PMID: 22867129]
  45. Tob Control. 2006 Feb;15(1):35-8 [PMID: 16436403]
  46. J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):507-14 [PMID: 22825231]

MeSH Term

Attitude of Health Personnel
Clinical Competence
Curriculum
Education, Pharmacy
Faculty
Health Knowledge, Attitudes, Practice
Humans
Patient Advocacy
Preceptorship
Professional Role
Public Health
Schools, Pharmacy
Smoking Cessation
Smoking Prevention
Teaching
Tobacco Use Disorder

Word Cloud

Created with Highcharts 10.0.0tobaccopharmacycessationhealthusepublicpharmacistspatientsPharmacycomponentprovidingcounselingcarerolecontrolacademicDespitedecadesinitiativesremainsleadingknownpreventablecausedeathUnitedStatesCliniciansprovenpositiveeffectpatients'abilityquitstrategicallypositionedassistquittingAmericanAssociationCollegesrecognizespromotiondiseasepreventionkeyeducationaloutcomeeducationrequiredcurriculaensuregraduatespossessrequisiteevidence-basedknowledgeskillsinterveneFacultymembersteachingcessation-relatedcontentmustknowledgeableproficientcomprehensivepreceptorspracticingdirectpatientscreenprovideleastminimalroutineorganizationsestablishpoliciesresolutionsaddressingprofession'sprofessionworktogethereliminatesalespracticesettingsservicesrenderedpolicysmoking

Similar Articles

Cited By